Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli
Eric Armstrong, Anke Hemmerling, Steve Miller, Kerianne E Burke, Sara J Newmann, Sheldon R Morris, Hilary Reno, Sanja Huibner, Maria Kulikova, Rachel Liu, Emily D Crawford, Gloria R Castañeda, Nico Nagelkerke, Bryan Coburn, Craig R Cohen, Rupert Kaul, Eric Armstrong, Anke Hemmerling, Steve Miller, Kerianne E Burke, Sara J Newmann, Sheldon R Morris, Hilary Reno, Sanja Huibner, Maria Kulikova, Rachel Liu, Emily D Crawford, Gloria R Castañeda, Nico Nagelkerke, Bryan Coburn, Craig R Cohen, Rupert Kaul
Abstract
BackgroundBacterial vaginosis (BV) causes genital inflammation and increases HIV risk, whereas a vaginal microbiota dominated by Lactobacillus species is associated with immune quiescence and relative HIV protection. BV treatment reduces genital inflammation, but it is unclear whether this reduction is driven by a decrease in BV-associated bacteria or an increase in Lactobacillus species.METHODSTo evaluate the short-term effect of standard BV treatment on genital immunology and the vaginal microbiota, vaginal swabs were collected immediately before and after metronidazole treatment for BV and analyzed with multiplex ELISA, metagenomic sequencing, and quantitative PCR.RESULTSTopical metronidazole treatment rapidly reduced vaginal levels of proinflammatory cytokines, chemokines, and soluble immune markers of epithelial barrier disruption. Although the vaginal microbiota shifted to dominance by L. iners or L. jensenii, this proportional shift was primarily driven by a 2 to 4 log10-fold reduction in BV-associated bacteria absolute abundance. BV treatment induced no change in the absolute abundance of L. crispatus or L. iners and only minor (<1 log10-fold) increases in L. gasseri and L. jensenii that were not independently associated with reduced inflammation in multivariable models.CONCLUSIONThe genital immune benefits that are associated with Lactobacillus dominance after BV treatment were not directly attributable to an absolute increase in lactobacilli, but rather to the loss of BV-associated bacteria.Trial REGISTRATIONParticipants were recruited as part of a randomized controlled trial (ClinicalTrials.gov NCT02766023) from 2016 to 2019.FUNDINGCanadian Institutes of Health Research (PJT-156123) and the National Institute of Allergy and Infectious Diseases (HHSN2722013000141 and HHSN27200007).
Keywords: Bacterial infections; Cytokines; Immunology; Microbiology.
Conflict of interest statement
Conflict of interest: CRC is a paid consultant for Osel Inc.
Figures
References
- Gosmann C, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity. 2017;46(1):29–37. doi: 10.1016/j.immuni.2016.12.013.
- Ravel J, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci. 2011;108(suppl_1):4680–4687.
- McKinnon LR, et al. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res Hum Retroviruses. 2019;35(3):219–228. doi: 10.1089/aid.2018.0304.
- Atashili J, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493–1501. doi: 10.1097/QAD.0b013e3283021a37.
- Kaul R, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol. 2008;77(1):32–40. doi: 10.1016/j.jri.2007.02.002.
- Arnold KB, et al. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol. 2016;9(1):194–205. doi: 10.1038/mi.2015.51.
- Nugent RP, et al. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301. doi: 10.1128/jcm.29.2.297-301.1991.
- Amsel R, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14–22. doi: 10.1016/0002-9343(83)91112-9.
- Anahtar MN, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015;42(5):965–976. doi: 10.1016/j.immuni.2015.04.019.
- Jaspers E, Overmann J. Ecological significance of microdiversity: identical 16S rRNA gene sequences can be found in bacteria with highly divergent genomes and ecophysiologies. Appl Environ Microbiol. 2004;70(8):4831–4839. doi: 10.1128/AEM.70.8.4831-4839.2004.
- Segata N, et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012;9(8):811–814. doi: 10.1038/nmeth.2066.
- Heid CA, et al. Real time quantitative PCR. Genome Res. 1996;6(10):986–994. doi: 10.1101/gr.6.10.986.
- Tettamanti Boshier FA, et al. Complementing 16S rRNA gene amplicon sequencing with total bacterial load to infer absolute species concentrations in the vaginal microbiome. mSystems. 2020;5(2):e00777-19.
- Lagenaur LA, et al. Connecting the dots: translating the vaginal microbiome into a drug. J Infect Dis. 2021;223(12 suppl 2):296–306.
- Joag V, et al. Impact of standard bacterial vaginosis treatment on the genital microbiota, immune milieu, and ex vivo human immunodeficiency virus susceptibility. Clin Infect Dis. 2018;68(10):1675–1683.
- Mayer BT, et al. Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis. J Infect Dis. 2015;212(5):793–802. doi: 10.1093/infdis/jiv079.
- Cohen CR, et al. Randomized trial of lactin-v to prevent recurrence of bacterial vaginosis. N Engl J Med. 2020;382(20):1906–1915. doi: 10.1056/NEJMoa1915254.
- Masson L, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260–269. doi: 10.1093/cid/civ298.
- Grabowska MM, Day ML. Soluble E-cadherin: more than a symptom of disease. Front Biosci (Landmark Ed) 2012;17:1948–1964. doi: 10.2741/4031.
- Anton L, et al. Common cervicovaginal microbial supernatants alter cervical epithelial function: mechanisms by which lactobacillus crispatus contributes to cervical health. Front Microbiol. 2018;9:2181. doi: 10.3389/fmicb.2018.02181.
- Nold C, et al. Inflammation promotes a cytokine response and disrupts the cervical epithelial barrier: a possible mechanism of premature cervical remodeling and preterm birth. Am J Obstet Gynecol. 2012;206(3):1–7.
- Symowicz J, et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res. 2007;67(5):2030–2039. doi: 10.1158/0008-5472.CAN-06-2808.
- Srinivasan S, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010;5(4):e10197. doi: 10.1371/journal.pone.0010197.
- Mohammadi A, et al. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility. Sci Rep. 2020;10(1):8514. doi: 10.1038/s41598-020-65544-6.
- Mayday MY, et al. Miniaturization and optimization of 384-well compatible RNA sequencing library preparation. PLoS One. 2019;14(1):8514.
- Saha S, et al. Unbiased metagenomic sequencing for pediatric meningitis in Bangladesh reveals neuroinvasive chikungunya virus outbreak and other unrealized pathogens. MBio. 2019;10(6):e02877-19.
- Balashov SV, et al. Multiplex quantitative polymerase chain reaction assay for the identification and quantitation of major vaginal lactobacilli. Diagn Microbiol Infect Dis. 2014;78:321–327. doi: 10.1016/j.diagmicrobio.2013.08.004.
- Kusters JG, et al. A multiplex real-time PCR assay for routine diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2015;34(9):1779–1785. doi: 10.1007/s10096-015-2412-z.
- Martin FE, et al. Quantitative microbiological study of human carious dentine by culture and real-time PCR: association of anaerobes with histopathological changes in chronic pulpitis. J Clin Microbiol. 2002;40(5):1698–1704. doi: 10.1128/JCM.40.5.1698-1704.2002.
Source: PubMed